Intarcia therapeutics, inc. – product pipeline review – 2012


Published on announce The Latest report -Intarcia Therapeutics, Inc. – Product Pipeline Review – 2012

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Intarcia therapeutics, inc. – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Intarcia Therapeutics, Inc. – Product Pipeline Review – 2012 link of Global Markets Direct Market Direct’s pharmaceuticals report, “Intarcia Therapeutics, Inc. - ProductPipeline Review - 2012” provides data on the Intarcia Therapeutics, Inc.’s researchand development focus. The report includes information on current developmentalpipeline, complete with latest updates, and features on discontinued and dormantprojects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Intarcia Therapeutics, Inc.’s corporate website, SEC filings,investor presentations and featured press releases, both from Intarcia Therapeutics,Inc. and industry-specific third party sources, put together by Global MarketsDirect’s team.Scope- Intarcia Therapeutics, Inc. - Brief Intarcia Therapeutics, Inc. overview includingbusiness description, key information and facts, and its locations and subsidiaries.- Review of current pipeline of Intarcia Therapeutics, Inc. human therapeuticdivision.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,
  2. 2. including the combination treatment modalities, across the globe.Table of contents:List of Tables 4List of Figures 4Intarcia Therapeutics, Inc. Snapshot 5Intarcia Therapeutics, Inc. Overview 5Key Information 5Key Facts 5Intarcia Therapeutics, Inc. – Research and Development Overview 6Key Therapeutic Areas 6Intarcia Therapeutics, Inc. – Pipeline Review 8Pipeline Products by Stage of Development 8Pipeline Products – Monotherapy 9Pipeline Products – Combination Treatment Modalities 10Intarcia Therapeutics, Inc. – Pipeline Products Glance 11Intarcia Therapeutics, Inc. – Late Stage Pipeline 11Phase III Products/Combination Treatment Modalities 11Intarcia Therapeutics, Inc. Clinical Stage Pipeline Products 12Phase I Products/Combination Treatment Modalities 12Intarcia Therapeutics, Inc. – Drug Profiles 13ITCA 638 13Product Description 13Mechanism of Action 13R&D Progress 13ITCA 638 + Ribavirin 14Product Description 14Mechanism of Action 14R&D Progress 15ITCA 650 16Product Description 16Mechanism of Action 16R&D Progress 16ITCA 880 18Product Description 18Mechanism of Action 18
  3. 3. R&D Progress 18ITCA 884 19Product Description 19Mechanism of Action 19List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview&PubId=&pagenum=1Infinity Pharmaceuticals, Inc. – Product Pipeline Review – 2012Intarcia Therapeutics, Inc. – Product Pipeline Review – 2012InterMed Discovery GmbH – Product Pipeline Review – 2012Jenrin Discovery, Inc. – Product Pipeline Review – 2012M et P Pharma AG – Product Pipeline Review – 2012Fresenius Biotech GmbH – Product Pipeline Review – 2012Evolva SA – Product Pipeline Review – 2012Glycotope GmbH – Product Pipeline Review – 2012Hawthorn Pharmaceuticals, Inc. – Product Pipeline Review – 2012
  4. 4. Helsinn Healthcare S.A. – Product Pipeline Review – 2012Hygeia Therapeutics, Inc. – Product Pipeline Review – 2012IkerChem S.L. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1You can also request for sample page of above mention reports onsample@aarkstore.comFor More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: